Clinical trial
Validation of RespiLife for Detection of Respiratory Suppression
NCT03819023 is registered in ClinicalTrials.gov with Bioresp Technologies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of RespiLife for Detection of Respiratory Suppression
- Lead sponsor
- Bioresp Technologies, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 20, 2018
- Completion date
- March 20, 2019
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.